When COVID-19 boosters first rolled out, many people wondered whether the extra shot was really worth it after completing their first two doses. Research from UVA Health in Virginia found one clear benefit: boosters don’t just raise antibody levels for a short time, they help that protection last longer.
How the study worked
The researchers measured antibody levels in blood samples taken between one week and five months after vaccination. They compared:
- About 230 people who had completed the two-dose primary series of an mRNA vaccine (Pfizer-BioNTech or Moderna)
- About 120 people who had received a booster dose
They also looked at whether age or a prior COVID-19 infection changed the results. The findings were published in Annals of Allergy, Asthma & Immunology.
What they found
The result surprised the team. In the first month after vaccination, antibody levels were about the same whether people had received the primary series or a booster. The difference showed up over time:
- Antibodies lasted longer after a booster. In the primary-series group, antibody levels dropped more quickly. In the booster group, they stayed higher for longer.
- The benefit held regardless of prior infection. People who had already had COVID-19 also saw more durable antibodies after boosting.
The researchers concluded that boosters improve the durability of the antibody response, which suggests better longer-term protection against infection than two doses alone. They noted that their results fit with other studies showing the same pattern.
Why durability matters
Antibodies are one of the immune system’s first lines of defense against the virus. When they fade, the chance of getting infected rises. The body has other defenses too, such as memory immune cells that help protect against severe illness, but longer-lasting antibodies can help keep infections from taking hold in the first place.
This matters most for people whose protection fades fastest, including older adults and people with weakened immune systems.
Interestingly, the team had expected boosters to drive antibody levels higher than the original two doses. Instead, the main gain was staying power. In practical terms, that means protection that holds up through more of the months that follow, rather than a short spike that quickly fades.
Keep in mind
This study looked at the original boosters in use in 2021 and 2022. COVID-19 vaccines have since been updated to better match newer variants, and recommendations about who should get them, and how often, continue to change. The general lesson still holds: protection fades over time, and staying up to date helps keep it strong.
Vaccines also aren’t the only factor. Overall health, age and how recently someone was infected all shape how protected they are.
What this means for you
- Ask about current recommendations. Your doctor or pharmacist can tell you which COVID-19 vaccine, if any, is recommended for you right now, based on your age and health.
- Don’t assume past infection is enough. Protection from infection fades too, and the study found boosting helped people who had already been infected.
- Plan around the season. Many people time their vaccines before winter, when respiratory viruses tend to peak.
- Combine layers of protection. Vaccines work alongside other habits, such as staying home when sick and improving indoor air during surges.
The bottom line
COVID-19 boosters didn’t push antibody levels much higher in this study, but they did help antibodies last longer. That extra durability is one more reason to stay current with recommended vaccines.
This article is for general information and isn’t medical advice. Talk with your healthcare provider about your individual needs.
